Skip to main content

Lluis Castells Fusté

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

Lluis Castells Fusté

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Aplicación de la tecnología de secuenciación masiva para optimizar el coste-efectividad del tratamiento de la hepatitis C (VHC) en la era de los inhibidores de acción directa (DAAs).

IP: Juan Ignacio Esteban Mur
Collaborators: Lluís Viladomiu Catà, Lluis Castells Fusté, Josep Quer Sivila, Cristina Dopazo Taboada
Funding agency: Instituto de Salud Carlos III
Funding: 192692.5
Reference: PI13/00456
Duration: 01/01/2014 - 31/01/2017

Complejidad de la cuasiespecie del virus de la Hepatitis B en las regiones X, precore y core: Asociación con la severidad de la infección

IP: -
Collaborators: Clara Ramírez Serra, Lluis Castells Fusté, Silvia Camòs Anguila, David Tabernero Caellas
Funding agency: Instituto de Salud Carlos III
Funding: 98373
Reference: PI12/01893
Duration: 01/01/2013 - 31/03/2016

Expansión/restauración funcional de células CD4 NS3 específicas autólogas en la prevención de la recurrencia VHC post-trasplante hepático: optimización del proceso para uso clínico

IP: Juan Ignacio Esteban Mur
Collaborators: Itxarone Izaskun Bilbao Aguirre, Lluis Castells Fusté, Silvia Sauleda Oliveras, Isabel Campos Varela, Marta Bes Maijo, Maria Madeleine Piron
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI10/01505
Duration: 01/01/2011 - 30/06/2014

Estudio dinámico de quasispecies de VHC por pirosecuenciación en fase aguda y crónica durante tratamiento antiviral (PIROVIRUSC)

IP: Josep Quer Sivila
Collaborators: Itxarone Izaskun Bilbao Aguirre, Lluis Castells Fusté
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 121000
Reference: SAF2009-10403
Duration: 01/01/2010 - 31/12/2012

Ministerio de Ciencia

Related news

The CHANCE study analyzes the outcomes of nearly 1,000 patients at 63 liver transplant centers and identifies which patients with the most severe forms of the disease may benefit from transplantation.

The grants support projects led by Drs. María José Buzón, María Buti, Elena Élez, and Maria Vieito.

The grants, amounting to more than €533,000 for VHIR, will allow clinical duties to be partially released over three years to promote strategic research projects in obesity, respiratory diseases, aortic pathology and metabolic fatty liver disease.

Related professionals

Rosa Alcaraz Peñarrocha

Rosa Alcaraz Peñarrocha

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Juan Bautista Torralba Paz

Juan Bautista Torralba Paz

Research technician
Maternal and Fetal Medicine
Read more
Ana Cindric

Ana Cindric

Senior researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Mar Xunclà Lloret

Mar Xunclà Lloret

Predoctoral researcher
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.